NEW YORK (Reuters Well being) – In patients with power myeloid leukemia (CML), discontinuing tyrosine kinase inhibitor (TKI) therapy is staunch and connected to better…
NEW YORK (Reuters Well being) – In patients with power myeloid leukemia (CML), discontinuing tyrosine kinase inhibitor (TKI) therapy is staunch and connected to better…